Skip to main content

KALA BIO, Inc 8-K, filed Nov 16, 2026

KALA BIO, Inc. (KALA)

8-K 2026-11-16 For: 2026-11-13
View Original
Added on November 16, 2026

About this 8-K

KALA BIO, Inc filed this 8-K on November 16, 2026, reporting on events of November 13, 2026.

Nasdaq granted KALA BIO, Inc. continued listing on The Nasdaq Capital Market, requiring a closing bid price of at least $1.00 per share from November 30, 2026 through February 23, 2027. The company had received a bid-price deficiency notice for July 16, 2026 through August 26, 2026. AI summary

Items reported

  • Item 8.01: Other events